Patent · US Active

Subcutaneous formulations of anti-CD38 antibodies and their uses

US10781261B2 · kind B2 · utility

10Cited by
14References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2019
Grant dateSep 22, 2020
Priority date—
Expiry dateApr 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.